CDTX
Cidara Therapeutics Inc.
Company Overview
| Mkt Cap | $2.67B | Price | $109.24 |
| Volume | 548.14K | Change | +0.19% |
| P/E Ratio | -15.7 | Open | $108.88 |
| Revenue | $1.3M | Prev Close | $109.03 |
| Net Income | $-169.8M | 52W Range | $12.74 - $121.21 |
| Div Yield | N/A | Target | $164.50 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 90 |
No chart data available
Stock Overview
Updated DailyCidara Therapeutics Inc. (CDTX) is a leading Healthcare company in the Biotechnology industry, currently trading at $109.24 with a market capitalization of $2.67 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CDTX with a volume of 548K shares. The stock opened down 0.14% from yesterday's close of $109.03. Current analyst estimates project earnings of $-4.88 per share for this year, with next year targeting $-7.81.
CDTX demonstrates very strong technical momentum based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including AGEN, ALKS, ENZN, ALIM.
Key investment considerations for CDTX include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 50.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:20 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CDTX | $109.24 | +0.2% | 548.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cidara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW